Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in the genetics of nonalcoholic fatty liver disease. | Curr Opin Gastroenterol | 2023 | 37144531 | PubTator, text mining | PubMed |
| Interdisciplinary advances reshape the delivery tools for effective NASH treatment. | Mol Metab | 2023 | 37142161 | PubTator, text mining | PubMed |
| The Role of Metabolic Dysfunction-Associated Fatty Liver Disease in Developing Chronic Kidney Disease: Longitudinal Cohort Study. | JMIR Public Health Surveill | 2023 | 37140958 | PubTator, text mining | PubMed |
| DNA polymerase gamma variants and hepatotoxicity during maintenance therapy of childhood acute lymphoblastic leukemia: is there a causal relationship? | Pharmacogenomics J | 2023 | 37138020 | PubTator, text mining | PubMed |
| Lean nonalcoholic fatty liver disease: Age-dependent differences in pathology, prognosis, and liver-related events. | Hepatol Res | 2023 | 37118869 | PubTator, text mining | PubMed |
Effect of a moderately carbohydrate-restricted diet on liver enzymes, steatosis and fibrosis in normal-weight individuals with non-alcoholic fatty liver disease: study protocol for a parallel randomised controlled clinical trial. | BMJ Open | 2023 | 37117000 | PubTator, text mining | PubMed |
| Applying Lipidomics to Non-Alcoholic Fatty Liver Disease: A Clinical Perspective. | Nutrients | 2023 | 37111211 | PubTator, text mining | PubMed |
| Identification of Metabolism-Related Proteins as Biomarkers of Insulin Resistance and Potential Mechanisms of m6A Modification. | Nutrients | 2023 | 37111057 | PubTator, text mining | PubMed |
| Screening for NAFLD-Current Knowledge and Challenges. | Metabolites | 2023 | 37110194 | PubTator, text mining | PubMed |
| Risk Scores for Prediction of Major Cardiovascular Events in Non-Alcoholic Fatty Liver Disease: A No Man's Land? | Life (Basel) | 2023 | 37109386 | PubTator, text mining | PubMed |
| HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis. | Int J Mol Sci | 2023 | 37108816 | PubTator, text mining | PubMed |
| Dysregulated Liver Metabolism and Polycystic Ovarian Syndrome. | Int J Mol Sci | 2023 | 37108615 | PubTator, text mining | PubMed |
| From Non-Alcoholic Fatty Liver to Hepatocellular Carcinoma: A Story of (Mal)Adapted Mitochondria. | Biology (Basel) | 2023 | 37106795 | PubTator, text mining | PubMed |
| Genetic variation and elevated liver enzymes during childhood, adolescence and early adulthood. | Int J Epidemiol | 2023 | 37105232 | PubTator, text mining | PubMed |
| Editorial: NAFLD, chronic kidney disease, and pleiotropy-Why is PNPLA3 omnipresent? | Aliment Pharmacol Ther | 2023 | 37094315 | PubTator, text mining | PubMed |
| Behavioural activity pattern, genetic factors, and the risk of nonalcoholic fatty liver disease: A prospective study in the UK Biobank. | Liver Int | 2023 | 37088982 | PubTator, text mining | PubMed |
| Waist circumference mediates the association between rs1260326 in GCKR gene and the odds of lean NAFLD. | Sci Rep | 2023 | 37081070 | PubTator, text mining | PubMed |
| Postprandial dysfunction in fatty liver disease. | Physiol Rep | 2023 | 37078380 | PubTator, text mining | PubMed |
| Integration of deep learning-based histopathology and transcriptomics reveals key genes associated with fibrogenesis in patients with advanced NASH. | Cell Rep Med | 2023 | 37075704 | PubTator, text mining | PubMed |
| Long-term hypercaloric diet exacerbates metabolic liver disease in PNPLA3 I148M animals. | Liver Int | 2023 | 37073116 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=40